Sector revisions Jaguar Health, Inc.

Equities

Delayed Nasdaq Other stock markets 08:56:39 16/07/2025 pm IST			5-day change	1st Jan Change
2.470 ^USD	+2.92%		-4.98%	-90.10%

25/06	Jaguar Health to Seek European Regulatory Approval for Dog Diarrhea Treatment	MT
11/06	Jaguar Health Establishes First Site for Canalevia-CA1 Field Study	MT

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Visibility (Composite)	Nbr of analysts
JAGUAR HEALTH, INC.		2
ELI LILLY AND COMPANY		27
JOHNSON & JOHNSON		23
ABBVIE INC.		27
NOVO NORDISK A/S		21
ROCHE HOLDING AG		19
NOVARTIS AG		18
ASTRAZENECA PLC		19
MERCK & CO., INC.		24
AMGEN INC.		28
PFIZER, INC.		23
GILEAD SCIENCES, INC.		26
VERTEX PHARMACEUTICALS INCORPORATED		28
SANOFI		22
BRISTOL-MYERS SQUIBB COMPANY		22
GSK PLC		18
CHUGAI PHARMACEUTICAL CO., LTD.		14
CALIWAY BIOPHARMACEUTICALS CO., LTD.	-	2
JIANGSU HENGRUI MEDICINE CO., LTD.		17
Average		20
Weighted average by Cap.		23